title: Approvals in 2016: questioning the clinical benefit of anticancer therapies.
authors.affiliation: Departments of Oncology and Public Health Sciences, Queen's University, University Avenue, Kingston, Ontario K7L 3N6, Canada.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Booth
authors.affiliation: Department of Medicine, Division of Medical Oncology, University of Toronto, King's College Circus, Toronto, Ontario M5S, Canada.
authors.forename: Joseph C
authors.initials: JC
authors.lastname: Del Paggio
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D017277:Drug Approval / Q000706:statistics & numerical data*; D016527:Drug Costs / Q000706:statistics & numerical data; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents